Public Health England has released figures showing that the number of people testing positive for Lyme disease was up over 30% in the period July to September 2015, from 300 lab confirmed cases to 421.
The figures are being highlighted by MSD Animal Health, organisers of the Bravecto 'Big Tick Project', a campaign to raise awareness of tick-borne disease amongst vets and pet owners.
The TV presenter and naturalist Chris Packham said: "The rise in the number of confirmed cases of Lyme disease in the UK reported by Public Health England suggests the need for greater awareness of this damaging illness. Vets have a huge part to play in educating pet owners.
"As well as highlighting the risks that ticks present to both human and companion animal health we need to be more alert to the signs and symptoms of tick-borne disease and the sensible steps we can all take to protect ourselves and our animals.”
Professor Richard Wall who has led Bristol University’s Big Tick Project team said: "Given the reported increase in cases of Lyme disease, the results of the Big Tick Project study will help us to understand these changes both in terms of the longer seasonal activity of ticks and their increasingly widespread geographic location and could have important implications for both human and animal health by quantifying the diversity and prevalence of the pathogens they may be carrying."
According to the NHS around 2,000 to 3,000 people in the UK are affected by Lyme Disease each year but charities campaigning for greater awareness of the disease suggest this could be as many as 15,000.
Growing concern over the rise in the tick-borne infection has prompted Government ministers to set up a network of regional experts to help diagnose and treat the problem.
Last autumn, Health Minister Lord Prior told a House of Lords debate: "Some patients suffer debilitating illness with symptoms that persist after treatment for several months or longer."
Lord Prior revealed that the Department of Health is to set up a network of experts around the country to support GPs and hospital staff, most of whom have never seen cases of the disease. The increase in the disease is being blamed on rising numbers of tick populations which are active for longer due to climate change, a rise in numbers of wild mammals such as deer that host them.
The clinical signs of Lyme disease in dogs include recurrent lameness due to inflammation of the joints. Sometimes the lameness lasts for only three to four days either in the same leg or in other legs and the joints may be swollen, warm, and painful. In some cases, kidney failure may occur and the dog may exhibit such signs as vomiting, diarrhoea, lack of appetite, weight loss, increased urination and thirst.
Orthomed has announced the launch of a series of four webinars covering a range of orthopaedic subjects.
The webinars are being presented by global diplomates and hosted by The Webinar Vet. They are:
Orthomed says the presentations are suitable for orthopaedic surgeons of all levels and interests, as well as those looking to get more involved in orthopaedic surgery.
The webinars are being held monthly, starting at the end of March.
The webinar series costs £97, which includes a £150 voucher to redeem against an Orthomed workshop.
In addition, the Webinar Vet has made 15 tickets available free of charge. To see if you can claim one, email Orthomed at info@orthomed.co.uk with the subject title Orthopaedic Webinar.
For more information, visit: https://www.thewebinarvet.com/orthopaedicexpertise
The BSAVA has launched a new guide to help practices navigate compulsory canine microchipping legislation which comes into force on 6th April.
The 18-page guide provides information on all aspects of microchipping, including the differing implications of the legislation across England, Scotland, Wales and Northern Ireland.
It explains exemption certificates that veterinary surgeons may be asked to sign, provides clarity on roles and responsibilities and more details on adverse event reporting, which will become a legal requirement under the new rules.
It also contains advice on when it is required or advisable to scan a dog in order to read the microchip and links to the updated RCVS guidance on microchips, microchipping and animals without microchips.
The guide has been accepted by the VMD and is supported by the RCVS.
The new microchipping legislation is aimed at improving animal welfare, promoting responsible ownership and tackling the illegal puppy trade. It is also hoped compulsory microchipping will improve collection of data on inherited diseases and disease outbreaks.
BSAVA President Tricia Colville (pictured right) said: "The BSAVA supports the permanent identification and registration of all dogs and cats, and other companion animals as appropriate, since the ability to individually identify an animal and trace the owner has the potential to improve animal welfare.
"Responsible pet ownership is at the core of the new legislation so as a profession we need to be clear on our responsibilities and do all we can to inform pet owners. We acknowledge that it may take time for the profession to adapt to the changes but this guide brings clarity and will prove helpful to vet practices across the UK."
The BSAVA is inviting members to report any problems they encounter to the BSAVA's Scientific Policy Officer Sally Everitt - s.everitt@bsava.com. The Association plans a further consultation at the end of the year to discover how the legislation enforcement has been received.
The guide will be available to members from the BSAVA website: www.bsava.com
A Market Harborough-based practice - Town & Country Veterinary Centre - has announced that it is entering a team into a 10km obstacle course race so gruelling it is called 'The Suffering'.
The Suffering takes place in the grounds of Rockingham Castle, Leicestershire, on Saturday 12 March 2016. It includes more than 25 water, mud and rope-based obstacles.
The Town & Country team, which includes vets, nurses, students and receptionists, hopes to raise £1,000 for Vets for Change, which is fundraising to vaccinate dogs in Africa against rabies.
Michael Lander MRCVS said: "We are big supporters of the work of Vets for Change which is currently fundraising for its next mass vaccination programme in South Africa. The race does sound gruelling and I have done no training as yet although some of my colleagues have been hitting the gym for the past couple of months. We will all pull together on the big day and getting everyone round the course is our goal.
"We'd be very grateful for donations to help us reach our target for Vets for Change which does such fantastic work and have set up a just giving page at https://crowdfunding.justgiving.com/townandcountry-veterinarycentre."
The team members are: Sarah Kay Robinson (Receptionist), Chloe Brown (Receptionist), Zara Lander (VN), Katy Kirkham (VN), Kathleen Gamble (VN), Grace Costall (Student VN), Kate Bodley (Small Animal Vet), Michael Lander (Small Animal Vet), Lucinda Ticehurst (Equine Vet).
Virbac has launched of Bovigen Scour, an emulsion for injection into cattle which reduces the severity of diarrhoea caused by bovine rotavirus, bovine coronavirus and enteropathogenic E.coli F5 (K99).
Bovigen Scour works by actively immunising pregnant cows and heifers and providing passive immunity to their calves via colostrum. According to the company, the vaccine also helps to reduce the shedding of virus by calves infected with bovine rotavirus and coronavirus.
Virbac says a key benefit of Bovigen Scour is the vaccination protocol which offers a large window for injection, making it easier for vaccination planning. The primary course is administered in two shots, with first dose between 12 and 5 weeks before calving and the booster 3 weeks later. The annual booster is then due between 12 and 3 weeks before calving is expected. The vaccine is presented in two sizes: 15ml (5 doses) and 90ml (30 doses). The dosage per cow is 3 ml and the withdrawal time is nil in milk.
Virbac Large Animal Product Manager Brigitte Goasduf MRCVS said: "Bovigen Scour offers farmers flexibility and ease of use. The flexibility it gives in terms of scheduling the primary course and booster is particularly important and is highly relevant for beef cattle farmers as it can be difficult to know exactly when a cow is likely to calve and it is vital not to miss the vaccination window.
"Bovigen Scour is also convenient to give because of the small volume of emulsion and because the injection is given intramuscularly. Its launch extends our large animal vaccine range, which includes Gudair, for the active immunisation of sheep and goats against Mycobacterium avium subspecies paratuberculosis (Map)."
A recent UK Mastitis Panel meeting, sponsored by MSD Animal Health, has concluded that a lack of expertise in drying off and teat sealant administration is the limiting factor preventing more widespread adoption of selective dry cow therapy protocols in UK dairy farms
The panel representing practising dairy vets, research and Government agreed that whilst the use of selective dry cow therapy was at a relatively low level in UK dairy herds at the moment, a momentum was building that could see as many as half the nation’s herds adopting the practice within a few years.
Dr Martin Behr, technical manager at MSD Animal Health and chair of the UK Mastitis Panel meeting, said: "There is growing pressure from the milk processors and some supermarkets to see a reduction in antibiotic use on dairy farms, and dry cow therapy is one area under the spotlight.
"We know from our own training workshops with vets and farmers that the level of expertise in administering teat sealants, for example, is relatively low. Only about 30 percent of vets attending these workshops had any experience at all in administering a teat sealant."
The view from many on the mastitis panel was that there was a knowledge gap on farms when it comes to dry cow therapy protocols and that this presented a significant opportunity for vet practices.
Dr Behr added: "Mastitis control in general offers vets an opportunity for proactive engagement with farmers, but it is a notoriously difficult area to establish routine work. With the pressure on farms to adopt selective dry cow therapy and the need for training, there is perhaps a new opportunity for practices with a real interest in mastitis control to build stronger and more preventative strategies with dairy farmers."
Veterinary practices with an interest in training on dry cow therapy and teat sealant use are advised to contact their MSD Animal Health account manager for details of future workshops.
Virbac has taken over the distribution of the prescription-only topical ectoparasiticide range, Activyl.
Activyl is available in three spot-on preparations: Activyl for Dogs and Activyl for Cats (flea control) and Activyl Tick Plus for tick and flea control in dogs. Based on the active ingredient indoxacarb, they are effective against developing flea life stages in the immediate environment of the pet.
Virbac Product Manager Kate Woolley MRCVS said: "Virbac is a global leader in parasitology and is using its knowledge and expertise to develop a portfolio of award-winning products. We are delighted to add Activyl to our range of parasiticides."
For more information, contact your Virbac Territory Manager.
Ceredigion veterinary surgeon Robert Alun Merfyn Evans has been suspended from the Register for six months by the RCVS Disciplinary Committee after he admitted to misconduct relating to tuberculin testing for cattle he owned and failing to register the births and deaths of cattle.
Mr Evans appeared before the Committee on the 11th February, when he admitted the two heads of charge of misconduct against him.
The first head of charge related to the fact that, between 24 June and 29 June 2013, he deliberately failed to bring to attention of Wyn Lewis MRCVS, an Official Veterinarian (OV) and fellow director of Mr Evans’ practice in Cardigan, the cattle on his farm requiring intradermal comparative tuberculin tests; that he tested certain of the cattle himself despite not being the OV for those tests and having a conflict of interest; and that he provided inaccurate and incomplete information to his practice for the completion of a report on the testing to be sent to the Animal Health and Veterinary Laboratories Agency (AHVLA). This misconduct was then repeated the following year between 19 June and 1 August 2014.
The second head of charge against Mr Evans related to breaches of the Cattle Identification (Wales) Regulations 2007 between 4 July 2005 and 20 June 2014, namely the fact that he failed to register the birth of five calves and the death of nine cows. These were accepted as being specimen charges reflecting a much larger total number of breaches over the whole nine year period.
Mr Evans’ misconduct first came to light when a late return was sent to the AHVLA in August 2014 regarding the TB testing of 51 live animals on his farm in June 2014. When the report was scrutinised the AHVLA noticed that 26 animals shown on the return as dead were still registered, while 20 animals that were tested were not registered. When the AHVLA investigated, Mr Evans immediately admitted that he had misled Mr Lewis on two occasions and carried out his own testing despite not being the OV.
The Committee heard that he did this because he did not want it to be found out that he had unregistered cattle on his farm. Regarding the unregistered cattle, the Committee heard that this stemmed from a mistake made by Mr Evans in 2005 or 2006 whereby he mislaid a batch of around nine bovine passport application forms sent to him to register the birth of calves on his farm, a legal requirement for the purposes of animal health, disease control and safeguarding the food chain.
As a result of poor IT skills and being profoundly deaf, Mr Evans felt unable to seek support online or by telephone, was too embarrassed to tell others and, furthermore, felt that it was impossible to correct his mistake without being in breach of the law. So, for a period of nine or 10 years, he failed to register the birth of calves on his farm. His failure to register the deaths of cattle, was also caused by administrative failings. His breaches of the cattle registration regulations were subject to criminal proceedings and on 14 October 2015 he plead guilty at Ceredigion and Pembrokeshire Magistrates Court to 14 offences for which he was given a conditional discharge for 18 months and ordered to pay costs of £1,000.
The Committee considered that a suspension from the Register would be in line with the seriousness of the charges against Mr Evans. Professor Alistair Barr, chairing the Committee and speaking on its behalf, said: "The Committee agrees that the lengthy period over which these offences took place, his betrayal of his colleague, and the undermining of the reputation of the profession and of the system of disease control, taken together with his dishonesty, make it impossible to impose a lesser sanction than suspension.
"The Committee finds that the respondent, who is a man of good character, has fully accepted his guilt, and has real insight into the seriousness of his conduct. He cooperated fully with the investigations and with the County Council who prosecuted him in the Magistrates [Court], and with the College. He made an open and frank admission about his misconduct from the outset.
"The course of conduct on which he embarked and which has led to these charges was the result of a simple mistake at a time of considerable stress to him. He was not guilty of deliberate misconduct at the outset but… what started as an innocent mistake took on a life of its own and led him to deliberate and dishonest misconduct because he did not know how to get himself out of the predicament he was in."
Professor Barr also said that there was no financial gain in Mr Evans’ actions and that animal welfare had not been compromised as the cattle were well cared for and in good health and that Mr Evans’ actions in carrying out the tuberculin tests on the unregistered cattle himself demonstrated that he was concerned about identifying any disease in his herd.
He added: “In all the circumstances the Committee has decided a proportionate sanction is that the respondent’s registration should be suspended for a period of six months.”
The Committee’s full findings and decision are available on the RCVS website (www.rcvs.org.uk/disciplinary).
MWI Animal Health, a part of AmerisourceBergen, has announced the acquisition of St. Francis Group, the UK’s largest animal health buying group.
The acquisition of St. Francis Group highlights AmerisourceBergen and MWI’s continued global expansion in the animal health sector, while also positioning MWI to better support the viability of independent veterinary practices internationally.
St. Francis Group, which represents more than 460 member practices throughout the UK and Northern Ireland, has steadily grown its member base and service offerings. The company aims to save its members time and money on veterinary products by providing information, technology and support that simplifies their processes, maximises purchasing benefits and reduces administration so members can focus on clinical care.
James F. Cleary, Jr., Executive Vice President and President, MWI Animal Health said: "At MWI, we’re focused on providing independent veterinary practices with the tools and resources they need to thrive in a competitive animal health marketplace. St. Francis Group is dedicated to this same mission and we believe that adding the resources of AmerisourceBergen to their existing expertise and tools will further strengthen the impact they’re able to create for their members."
Alan White, Managing Director, St. Francis Group, said: "We’re proud of the work we’ve done to encourage the health and viability of our member practices. We look forward to working with MWI and AmerisourceBergen to further expand our capabilities with the goal of providing even greater value to current and future members of St. Francis Group."
AmerisourceBergen completed its acquisition of MWI Veterinary Supply, Inc. in February of 2015. MWI completed the acquisition of Vetswest Limited, a leading veterinary support services provider in the UK in August of 2015.
MWI says that through the acquisition, St. Francis Group will continue to negotiate with manufacturers based their ability to best meet member needs and purchase products from preferred wholesaler partners.
For more information about MWI Animal Health, visit www.mwianimalhealth.com.
Bayer Animal Health has launched its annual tick awareness campaign, this year titled 'No Bite is Right', with results of a survey which found that 44% of pet owners don't use regular preventative tick treatment.
The OnePoll survey of 4000 pet owners, which was conducted on behalf of the company in January, also found that 60% of pet owners are worried about ticks spreading disease to their pet, and 28% have found one.
As part of the 'No Bite is Right' campaign, owners are being encouraged to speak to their veterinary surgeon about using preventative tick products to help reduce the risk of their pet becoming infected by tick-borne diseases.
Jenny Helm, University of Glasgow Veterinary Clinician, said: "In recent years I have noticed and been made aware from owners and other vets, of a steady rise in tick numbers across the country. With this there is an increased risk of potentially fatal tick-borne diseases being transmitted to pets. However, if a tick can be killed before it bites, this avoids the risk and provides vital protection to the pet."
Richard Wall, Professor of Zoology at Bristol University, said: "Research has shown that in recent years, tick abundance has increased and the period of seasonal activity has extended in many areas. Climate change, particularly warmer, wet winters have had direct effects on tick feeding as well as impacting indirectly on vegetation cover and creating a more suitable habitat. The increase in deer numbers, habitat modification by conservation and changes in farming practices have also all contributed to the growth in numbers."
Stella Huyshe-Shires, from charity Lyme Disease Action, says: "Lyme Borreliosis is a rapidly emerging disease in the UK and a number of experienced healthcare professionals believe the increase in reported cases reflects a genuine rise over the last 20 years, and not just increased awareness leading to more diagnosis. There appears to have been an increase in ticks and, in turn, an increase in the prevalence of Lyme borreliosis in ticks."
'No Bite Is Right' is part of Bayer Animal Health’s wider 'It’s a Jungle Out There' parasite protection initiative. A series of campaign roadshows for pet owners will be taking place this year at the Ayr, Devon and New Forest County Shows. You can find out more about how your practice can get involved with the campaign by following the conversation on www.facebook.com/jungleforpets and downloading campaign materials at www.vetcentre.bayer.co.uk.
Zoetis has launched a one-dose vial of Rispoval IntraNasal, in order to offer respiratory health protection in calves as soon as possible after birth without either waiting to batch them in groups or wasting unused vaccine in multi-dose packs.
To make ready for use, the vaccine is reconstituted by mixing a powder with sterile diluent. Once mixed, the licensed shelf life is two hours. This means any that is unused in multi-dose packs must be thrown away. By stocking a combination of one- and multi-dose packs, farmers can eliminate this.
The vaccine protects against two primary viral causes of pneumonia in young calves, BRSv and Pi3v1. Surveillance of blood samples from 2,145 calves with pneumonia signs found 78% exposed to BRSv, 81% to Pi3v2. The product licence allows use from nine days of age, with onset of immunity to BRSv and Pi3v after five and 10 days respectively. The licence also specifies a duration of immunity of 12 weeks.
Zoetis vet Carolyn Hogan says that viruses are the instigator of a majority of respiratory health problems: "Early-life protection also helps reduce the threat from opportunistic secondary bacterial infections, such as Pasteurella.
"Good respiratory health is essential to ensure calves develop to achieve their lifetime potential. But it's estimated that 67% of pneumonia cases occur in calves less than three months of age3.
"Whether suckled or reared, calves that don’t grow effectively in the early weeks are unlikely to catch up later. On both dairy and beef units, proactive management of the calf living space, nutrition and disease resilience is critical to maximise lifetime productivity, which is clearly so important under today's farm business economics.
More information about the benefits of managing respiratory health in calves is available at plantoproduce.co.uk.
Virbac has launched Propofol-Lipuro Vet, a short-acting intravenously administered and short-term maintenance general anaesthetic for use in dogs and cats.
Propofol-Lipuro Vet contains no preservatives so its use can be repeated, even in cats, for continuous rate infusion. No age restrictions apply to the animals it can be used for and it can be administered for induction prior to Caesarean section.
Virbac Product Manager Kate Woolley MRCVS said: "Propofol is a well-established solution for short-acting anaesthesia in many practices. Propofol-Lipuro Vet complements Virbac's anaesthesia range which now offers total control of analgesia, sedation, intravenous and gaseous anaesthesia, and recovery."
Propofol-Lipuro Vet is available in boxes of 10 x 20 ml bottles.
Ceva Animal Health has extended its Meloxidyl dogs and cats’ range with the launch of a new 5ml Meloxidyl oral suspension for cats.
The company says the new bottle size will provide more prescription options for veterinary practices currently stocking 15ml bottles and is a perfect post-surgery size to send patients home with. The bottles are also clear brown in colour; designed to make it easier for cat owners to see how much liquid is left in each bottle.
Meloxidyl oral suspension for cats contains meloxicam for the alleviation of pain and inflammation. It is licensed for the treatment of musculo-skeletal disorders and the alleviation of post-operative pain.
Rob McLintock, business unit manager at Ceva Animal Health said: "The new 5ml Meloxidyl oral suspension for cats’ bottle will provide veterinary practices with more prescription options for the management and alleviation of pain and inflammation in cats."
To support the launch of the new 5ml Meloxidyl presentation, Ceva is running a competition to win one of five BSAVA Manuals of Anaesthesia and Analgesia by answering one question: ‘How many millilitres are in the new Meloxidyl cat bottle’?
To enter the competition, email analgesics-group@ceva.com. Include ‘Meloxidyl competition’ in the subject line and contact details and the answer to the question in the main body of the email.
For further information on Ceva’s analgesic product range, contact your local Ceva territory manager, email analgesics-group@ceva.com or call 01494 781510.
VetSurgeon.org has launched a completely revamped classified jobs section for the profession which allows members to subscribe for alerts when someone advertises a vacancy in their area.
VetSurgeon Jobs has been designed from the ground up to be as simple as possible for job-seekers to find the right vacancy. By default, jobs are listed in the order they were posted. But enter a location (ideally your postcode) and the list re-orders by distance from that location. Simple as that. No login required.
You can also set other criteria, such as small animal vet jobs only, to further whittle down the selection.
The subscription service works on the same basis. In most cases, you'll probably just want to enter a postcode and a distance from that postcode that you're interested in. But you can also add further filters so you are notified only of, say, locum or small animal positions. And for those locums who work in multiple locations, you can set up multiple subscriptions.
For advertisers, we thought of only one thing, which was how can we offer more bang for your buck than the alternatives (besides being presented on the most popular veterinary website for eight weeks). That question influenced every aspect of the design and functionality of the new, improved VetSurgeon Jobs.
In due course, VetSurgeon.org will introduce a charge for advertising. However, the site is and always has been about supporting the profession, and the pricing will reflect that: no more than £150 +VAT in 2016.
Virbac has announced the launch of Speed Trio, an in-house diagnostic test to enable the detection of FeLV (Feline Leukaemia Virus) antigens; anti-FIV (Feline Immunodeficiency Virus) and anti-FCoV (Feline Coronavirus) antibodies in 15 minutes.
The company says Speed Trio is designed to facilitate the diagnosis of immunosuppressive diseases, such as FIP (feline infectious peritonitis); when a cat tests positive for Feline Coronavirus and either FeLV or FIV it is at increased risk of developing FIP¹ and serological testing for all three diseases is the logical step.
Virbac says it has also enhanced the entire Speed range to further improve the readability of the tests and the brightness of the test bands.
Product Manager Madeline Haynes said: "The Speed range, which has been proven in practice for more than 20 years, offers a comprehensive suite of in-house diagnostic tests, which are easy to perform and highly cost-effective to use in practice.
"Speed Trio is not only a unique test combination that helps to facilitate diagnosis of immunosuppressive diseases but also boosts client satisfaction and can support practice profitability."
Reference
Members of the XLVets, a collaborative group of independent veterinary practices across the UK, have raised over £35,000 in a recent charity challenge to travel the world without an engine.
To mark the 10th anniversary of XLVets, all 53 member practices together travelled a total of 34,727 miles to complete the challenge, the equivalent of almost one and a half times around the world, by running, kayaking, swimming, cycling and walking their way thoughout the UK.
Alex Cooper of Pembrokeshire based Fenton Vets raised the most, totalling £1,966.04, whilst his practice also clocked up the furthest distance, travelling 4,516 miles. He said: "The day took some coordinating with a horsebox carrying bikes and kayaks. The enthusiasm created amongst the team meant it became the talking point within the practice for weeks. It even reached the local press!"
He added: "We have already decided that it will become an annual event with invites extended to clients as well as all XLVets member practices."
Organiser Jane Simpson said: "The money raised has been split between member practices’ local chosen charities and Send a Cow, which will receive a cheque for £15,571.00."
Sophie Porfirio, corporate partnerships manager for Send a Cow is delighted with the donation: "It’s a big fat thank-moo(!) from everyone at Send a Cow to everyone at XLVets who have made this fabulous donation possible. We don’t put cows on planes anymore, so they aren’t doing the mileage the XLVets teams have been achieving in recent months, but we do go to great lengths to provide the skills training, livestock and support so that some of Africa’s poorest families are able to help themselves. This donation ensures hundreds of people have food security and the knowledge to future-proof their families for generations to come. It’s an incredibly special gift and we really appreciate it."
Jane said: "The XLVets practices have shown how independent practices can work together to achieve amazing results. The generosity of all those that have supported our efforts will make a real difference to the charities. It's a great achievement and I am sure that the resourceful and competitve nature of all of our members will mean that our fundraising efforts will not stop here."
Shor-Line has announced the launch of YesWeCanSee, a webcam system which allows veterinary surgeons to monitor inpatients from anywhere, over the internet.
The system allows you to watch, listen to and record or photograph the patient remotely. In addition, there is a built-in light which can be used to illuminate or stimulate the patient.
Steffan Veterinary Services, a seven-vet mixed practice based in Lampeter, Ceredigion, recently bought the system and used it to monitor a RTA patient. Jim Hopkins, a director at the practice said: "Boio was unfortunately run over by his owner. He was brought to the practice and hospitalised for monitoring and treatment. Due to his status on arrival he was given pain relief and intravenous fluids. He was kennelled and kept quiet with minimal disturbance. The camera was used to avoid unnecessary contact. The camera could also be turned to check that the IV fluids were running. Once stable and pain relief was working he was radiographed and fully examined. There was a slight increase in respiratory rate but he was otherwise OK. He was kept overnight and monitored. During the evening when checked in person, Boio was settled and not showing any pain, however when remotely monitored he was pacing the kennel and appeared anxious. Further pain relief, Vetergesic, was administered and then Boio settled for the night. Without the camera it is unlikely he would have had further Vetergesic. The following morning Boio was sore but well enough to return home. He has since made a full recovery”.
For more information about YesWeCanSee, visit: www.yeswecansee.com, contact Dan Puddick on 01446 772041 or email ywcs@shor-line.co.uk
Norbrook has announced the launch of Marbodex Aural, the most recent addition to its Otitis Management System for dogs.
Norbrook says the ingredients in Marbodex Aural (marbofloxacin, clotrimazole, dexamethasone) are proven to relieve pain and inflammation quickly, deal with key bacterial and fungal infections effectively and thereby improve pet comfort.
The company says the inclusion of marbofloxacin makes Marbodex Aural an ideal first choice for cases of otitis externa that are:
Marbodex Aural also contains clotrimazole, a broad spectrum antifungal effective against otitis caused by Malassezia pachydermatis, and dexamethasone, a fast acting steroid whose absorption is not increased in inflamed ears.
Marbodex Aural is applied once a day and has two soft nozzles to reduce pain on application and prevent cross-contamination during treatment. It can be used for extended treatment periods of seven to fourteen days when treating persistent infections.
Marbodex Aural is available in all veterinary wholesalers now. For more information about Marbodex and to take advantage of the launch offers, contact your Norbrook Territory Manager or call 01536 741147 for more information.
Reference:
The International Veterinary Epilepsy Task Force (IVETF), a group of 26 veterinary practitioner, neuropharmacology, neuropathology and neurology experts led by Holger Volk, Professor of Veterinary Neurology and Neurosurgery at the RVC, has issued new guidelines for treating and caring for dogs with epilepsy.
The guidelines have been adopted by the American College of Veterinary Internal Medicine (ACVIM) and published in the form of a ‘consensus statement’ in the Journal of Veterinary Internal Medicine (JVIM).
Professor Volk, who co-chaired the consensus statement process, said: "I was honoured to have been asked to co-chair such an important forum in American veterinary practice. This will be another landmark paper to help improve the care vets deliver for the patients with epilepsy, both in America and beyond.
"Epilepsy is one of the most common neurological diseases encountered by veterinary surgeons and practitioners around the world. The prevalence of the condition means there have been numerous research studies carried out over the years. But, despite such frequent research, there has been a lack of consistency when it comes to diagnosis and treatment.
"This lack of cohesion and collaboration made it difficult for owners and veterinary professionals to communicate effectively on the issue of pet epilepsy. This has led to the global veterinary community changing its approach and, in recent years, working more closely together."
Professor Volk says the aim of these latest guidelines is to provide joined up and collaborative thinking, teaching and learning on various different aspects of the condition that specifically affect America. These include the development of treatment strategies and any potential issues with chronic anti-epileptic drug treatment.
The ACVIM guidelines follow on from seven in-depth consensus statements produced by the IVETF and published open access in BMC Veterinary Research last year, outlining recommendations and classifications on all aspects of canine epilepsy. It was the first time this many veterinary neurology clinicians and neuroscientists formally agreed on the key aspects of the condition.
Professor Volk, who is also the Clinical Director of the RVC’s Small Animal Referral Hospital, added: "There is a real exciting buzz around canine and feline Epilepsy currently. Finally getting to global consensus from the international veterinary community will accelerate research and lead to improved patient care and quality of life for owners and patients alike."
Zoetis has announced that Horse & Country TV (Sky Channel 253) will be airing the Vet Essentials episode on worm control in horses from today until 26th March.
The programme, made in association with Zoetis, follows presenter Jenny Rudall on her mission to explore every aspect of worming horses, including how to tackle encysted small redworm. Jenny talks to vet Ben Gaskell from Minster Vets for the low down on worm control, before heading off to the Moredun Research Institute in Scotland to meet parasitology experts Jacqui Matthews and Thomas Tzelos to find out more about the role of faecal worm egg counts, the damage that can be caused by worm burdens and the growing problem of resistance.
Zoetis vet Wendy Talbot said: "The programme should be a big help to vets when it comes to explaining worming to horse owners. They can tell their clients about it and encourage them to watch. It will help educate them about all aspects of worming and specifically about the threat of encysted small redworm at this time of year. This, in turn, should help protect horses against this potentially fatal parasite."
The company is encouraging the profession to help spread the word about the new to clients by email, via Facebook and by word of mouth.
Elanco Animal Health has launched #PetMagicMoments, a social media campaign designed to drive engagement between veterinary practices and their clients and encourage customer footfall to veterinary practices.
As part of the #PetMagicMoments campaign, the company is inviting veterinary professionals and pet owners to share some of the magic moments they've had with their pet on Facebook, Twitter and Instagram. There's a weekly prize of a personalised photo cushion for the image that gets the most likes, shares or retweets, and a main prize draw for £500 worth of Forest Holidays’ vouchers.
In addition, Elanco is asking veterinary practice staff to share heart-warming stories that happen in practice, using the hashtag #VetMagicMoments. The practice that shares the most popular post or tweet will win a monthly prize of a £250 restaurant voucher.
Elanco has produced a launch pack to support the campaign and promote it to colleagues and clients. The pack includes:
Matthew Rowe, Milbemax marketing manager at Elanco Animal Health, said: "Facebook users account for 90% of all UK social media users1 with nearly one in four dogs and cats having their own social media feed or page2. Our #PetMagicMoments campaign will build a community of pet owners, vets and vet nurses who share the love they have for their pets, while driving engagement between veterinary practices and their clients on social media and encouraging customer footfall direct to the veterinary practice which will lead to increased revenues for veterinary practices."
Elanco says it will also be sharing worming advice, pet related information, news, statistics and competitions and quizzes, which will all be available for veterinary practices to share via their own social media.
To sign up for the #PetMagicMoments campaign visit www.petmagicmoments.com and download the campaign guide.
For further information, contact your local Elanco Animal Health territory manager.
Biobest is highlighting the benefits of using its canine prostate specific arginine esterase (CPSE) test to differentiate between those dogs which have benign prostatic hyperplasia and those suffering more serious conditions, such as neoplasia.
Benign prostatic hyperplasia is a common condition of entire dogs with over 50% of dogs over 5 years of showing histological evidence of BPH.
Paul Burr MRCVS from Biobest said: "While the clinical stages of prostatic disease are not difficult to diagnose, differentiating BPH from other causes of prostatic disease such as prostatic cysts, prostatitis, prostatic abscesses or neoplasia is less simple. Traditionally further investigation would include bacteriology and cytology on a prostatic wash or final needle aspirate, and prostatic ultrasonography."
Although the CPSE test has been available for a couple of years now, Paul says the benefits of the test have not thus far been well-explained: "I think most vets probably think it's just a test for Prostatic Disease, something which is easy enough to diagnose without testing.
"While the test can be used as part of an annual check up to look for pre-clinical BPH in entire male dogs, it's real value is that it is a simple, convenient non-invasive blood test that helps determine whether a dog presenting with signs of prostatic disease is most likely to be suffering from BPH or a more serious condition that requires further investigation."
For more information about the CPSE test, contact Biobest on 0131 440 2628 or email enquiry@biobest.co.uk.
Norbrook has announced the re-launch of its range of intramammary tubes for lactating and dry cows, to promote holistic herd health and responsible use of antimicrobials.
The company’s range, which includes products across a number of antibiotic classes, primarily targets clinical cases of mastitis in lactating cows, and removal or prevention of infection around the dry period.
Chris Geddes MRCVS, Marketing Manager at Norbrook, says the re-launch is focused on modernising the range and making it clearer for practice staff and farmers to avoid confusion between lactating cow and dry cow products: “We have a wide range of 11 products containing a variety of antimicrobials: for example Duofast is the only lactating cow product to contain trimethoprim and sulfadiazine. We are working with vets to promote responsible use by farmers, for example through the use of our teat sealant Noroseal for Selective Dry Cow Therapy."
The full range includes Duofast, Lactaclox, Cefimam LC, Combiclav, Noroclav and Multiject for the lactating cow; Cefimam DC, Noroclox, Bovaclox and Bovaclox DC Xtra for the dry cow; and teat sealant Noroseal.
Norbrook has also produced a best practice guide to mastitis control, available for vets in English and Polish, which can be shared with farmers.
Chris added: "We recognise the need to reduce overall use of antimicrobials, especially for disease prevention – as well as using non-antimicrobial products such as teat sealants. These practices, together with the recent focus on using older classes of antimicrobials, mean that as an industry we need to adopt a holistic and targeted approach to herd health management.
"We believe that by providing additional information to aid with prevention of disease, and re-launching our intramammary range to make it clearer when products should be used, we can help to achieve that."
Norbrook says the full range of products is in stock, but some wholesalers may hold components of the old range as the new range is phased in.
The University of Bristol’s School of Veterinary Sciences has announced the launch of an online map-based tool which forecasts the risk of a Nematodirus outbreak in lambs.
The Nematodirus risk map, which will be updated daily, is designed to help UK sheep farmers assess the risk of outbreaks of the parasite in their lambs and take action before it is too late. It includes treatment and management advice.
The online risk forecast was developed by SCOPS (Sustainable Control of Parasites in Sheep) and researchers at the University of Bristol’s School of Veterinary Sciences to predict when Nematodirus eggs will hatch and when outbreaks are likely to happen.
Researchers say that predicting when outbreaks might happen is becoming increasingly difficult due to variation in spring temperatures from year to year. Farmers can no longer rely on a standard timetable of treatments to avoid disease. As the damage is done by the larvae, faecal egg counts are of little use in detecting and controlling Nematodirus in young lambs.
The forecast takes advantage of the temperature-driven synchronised hatching of the Nematodirus larvae and uses weather data from 140 weather stations provided by the Met Office and Forecast.io. The interactive Google map allows farmers and advisers to select the nearest or most representative weather station and provides advice on how to relate the predicted risk to their particular farm and treatment options.
Cases of nematodirosis and eggs detected in routine faecal worm egg counts will also be mapped anonymously as they arise to improve the forecasts and SCOPS are asking farmers, advisors and diagnostic labs to contribute to these records by emailing researcher Dr Hannah Rose at the University of Bristol’s Vet School.
Dr Rose said: "In previous years 64 per cent of farmers and advisors surveyed changed the timing or extent of treatment – or advised treatment - after consulting the forecast, which has been running since 2013, and 93 per cent felt that their approach to control of this parasite had changed as a result of the forecast."
UK Government funding provided by the Biotechnology and Biological Sciences Research Council has enabled further development of the forecast and it is hoped that even more farmers will benefit in 2016.
Picture: A Romney sheep with its lambs, courtesy Dr Eric Morgan, University of Bristol
The International Society of Feline Medicine (ISFM), the veterinary division of International Cat Care, has announced the publication of the new ISFM Consensus Guidelines on the Diagnosis and Management of Feline Chronic Kidney Disease in this month's Journal of Feline Medicine and Surgery1.
The guidelines represent the consensus of an expert panel of clinicians and academics gathered from the UK, France, Australia and North America. In making their recommendations, the panelists considered various management approaches and graded the quality of the available published evidence with respect to their impact on quality of life and longevity.
The authors say dietary management is supported by good evidence. Notably, specific commercial renal diets have been shown to significantly prolong longevity and improve quality of life. A common problem, however, is poor acceptance of these diets, which are generally less palatable than maintenance diets, and the guidelines include a number of recommendations to assist in transitioning cats to a new diet.
Other interventions with good supportive evidence are routine assessment of blood pressure in cats with CKD, and use of antihypertensive medications (when indicated) to help protect organs at particular risk of damage, such as the eyes and heart.
Given the chronic nature of CKD, the guidelines, which are free to access and download, emphasise how vital it is for the veterinary clinic to establish a good relationship with the cat’s owner. This will facilitate treatment plans to be created that take into consideration the wishes and ability of the owner, as well as the needs of the individual cat.
You can read the guidelines here. There is also a podcast recording of the panel chairman Dr Andrew Sparkes discussing the guidelines is available here.